Sunnyvale, CA, and San Francisco, CA. 7 December 2016.  Labcyte Inc. and Notable Labs today announced a collaboration to apply the uni... Read more

Seroba’s investee company, Opsona Therapeutics Ltd (‘Opsona’), the innate immune drug development company focused on novel therap... Read more

Seroba’s investee company, Opsona Therapeutics Ltd (‘Opsona’), the innate immune drug and development company focused on novel th... Read more

The MIMICS-2 study is a prospective, multicentre, interventional study designed to evaluate the safety and effectiveness of BioMimics 3... Read more

TOP